Ingen Technologies, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IGNT research report →
Companywww.ingen-tech.com
Ingen Technologies, Inc. , a medical device manufacturing company, manufactures medical products for the respiratory industry in United States. The company manufactures medical equipment for patients suffering with chronic obstructive pulmonary disease; and oxygen flow meters and nasal cannulas under the Oxyview and Smart Nasal Cannula trademark name.
- CEO
- David S. Hanson
- IPO
- 2009
- Employees
- 5
- HQ
- Riverside, CA, US
Price Chart
Valuation
- Market Cap
- $1.79K
- P/E
- -0.05
- P/S
- 132.10
- P/B
- -0.00
- EV/EBITDA
- 0.00
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 95.70%
- Op Margin
- -4821.23%
- Net Margin
- -7460.38%
- ROE
- 0.02%
- ROIC
- 276.67%
Growth & Income
- Revenue
- $13.565 · -99.79%
- Net Income
- $-1,012 · 99.87%
- EPS
- $-0.00 · 80.00%
- Op Income
- $-654
- FCF YoY
- 116.77%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -5.81
- Avg Volume
- 15
Get TickerSpark's AI analysis on IGNT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our IGNT Coverage
We haven't published any research on IGNT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IGNT Report →